This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Member Connect   Tech Transfer   Events   Publications   Marketplace Dec. 16, 2010

Report highlights positive impact of academic innovations on quality of life
Newswise    Share   Share on FacebookTwitterShare on LinkedinE-mail article
A device that allows the blind to — see via electrical pulses applied to the tongue, a collagen scaffold to treat damaged joints, a new vaccine to prevent shingles, an artificial lung that provides patients with both mobility and comfort during treatment, a program that vastly improves literacy among middle and high-school age students, a device that transforms wheelchairs into all-terrain vehicles and a vaccine to prevent HPV. These are just a few of the discoveries featured in the 2010 edition of the AUTM Better World Report, a collection of stories about technologies that originated in academic research and were brought to the public through technology transfer, the process of licensing and commercializing academic research so it can become real products that make the world a healthier and safer place. More

Supreme Court case could deprive inventors and businesses of ability to commercialize inventions    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An important case now before the Supreme Court may soon reconfigure ownership of all student and faculty inventions. The Supreme Court agreed to hear the appeal of Stanford University v. Roche Molecular Systems, Inc.; faculty and student inventors, the public, and American industry have an enormous stake in the Court's decision. The appeal pits university patent administrators against university inventors. If the administrators win, university inventors will have no invention rights — not in the work they do at the university, and not in the work they do in the community. More

University of Glasgow in UK, decides to give away its research to those who can use it best
The American University Washington College of Law    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Over 30 years ago, the Bayh-Dole Act was seen as a surefire way to increase research and development in the U.S. By enabling universities to retain the titles to their federally-funded research, Congress hoped that universities would be more inclined to advance science and file patents. After filing for the patents, the universities should have licensed their research to anyone and everyone, thus facilitating faster commercialization and eventually benefiting the public in a much more effective way than any federal lab could. Studies have shown though, that in these 30 years, the research is not getting out to the public any faster. How do we get the research, patents, and simple scientific improvements out to the people faster? More

Yissum introduces a novel method for forensic DNA profiling
BusinessWire via Benzinga    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Forensic DNA science has advanced significantly in the latest decade, and constitutes today the mainstay of forensic science. All serious crime scenes are routinely inspected for DNA evidence and many cases are solved by matching the DNA in the crime scene to that of a suspect. But often a crime scene will contain complex DNA mixtures (usually more than two individuals), and the detection of a particular DNA profile in such mixtures is challenging. Consequently, in such cases current police practices overlook valuable information that may aid in solving serious crimes. Now, Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, introduces a novel method for identifying a suspect's DNA even in complex DNA mixtures. More

Nevada nonprofit announces clean tech partnership
RGJ    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Nevada Institute for Renewable Energy Commercialization announced its new partnership with the Lawrence Berkeley National Laboratory to speed up commercialization of clean technology developed by the research facility. More

Genetically engineered microorganism metabolizes waste into methane
EP Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A University of Arkansas researcher and his colleagues have created the first methane-producing microorganism that can metabolize complex carbon structures, which could lead to microbial recycling of waste products and their transformation into natural gas. Daniel J. Lessner, assistant professor of biological sciences, and his colleagues Lexhan Lhu, Christopher S. Wahal and James G. Ferry of Pennsylvania State University, published their findings in mBio. Lessner conducted the research as a postdoctoral associate at Penn State. While methane gas is considered to be a greenhouse gas, it also is an important biofuel used to power businesses and homes. Finding ways to produce methane gas efficiently therefore interests individuals and industries alike. More

Safeguard your research mouse models

The Jackson Laboratory manages thousands of mouse models for the worldwide biomedical research community. Many are accepted by our repository at no cost and donor institutions may reserve commercial use rights. Learn more

Shrink Nanotechnologies acquires exclusive worldwide license to 'electronic glue'    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced that it had formed a wholly owned subsidiary called BlackBox Semiconductor, Inc. ("BlackBox"), and that BlackBox has entered into a worldwide multi-year exclusive license with the University of Chicago, licensing work based on Assistant Professor of Chemistry, Dmitri Talapin's "electronic glue" chemistry. The license covers all applications except for thermoelectric applications. More

New combo lung cancer therapy improves survival over single-line treatment
e! Science News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A combination therapy for treating cancer discovered at the University of Colorado Cancer Center showed improved survival rates in patients with advanced non-small cell lung cancer, according to results from a double-blind, placebo-controlled phase 2 trial run by Syndax Pharmaceuticals. The phase 2 results show that the combination of entinostat and erlotinib was more effective in treating NSCLC in patients with elevated levels of the molecular cancer marker E-cadherin than using erlotinib alone. University of Colorado Cancer Center researchers, who are faculty at the University of Colorado School of Medicine, were the first to identify elevated E-cadherin as a targetable cancer marker, the first to develop the biomarker tumor testing process for elevated E-cadherin and the first to test the combined therapy. More

Former USPTO Director and examiners.

FREE Disclosure Review Service. Call 1-800-4-PATENT or click here.

AUTM Newsbrief
Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Hailey Sasser, Content Editor, 469.420.2630

Contribute news
This edition of the AUTM Newsbrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec. 9, 2010
Dec. 2, 2010
Nov. 23, 2010
Nov. 18, 2010

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063